Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE LE BRIS GOUDAL : revenue, balance sheet and financial ratios

PHARMACIE LE BRIS GOUDAL is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in VALOGNES (50700), this company of category PME shows in 2023 a revenue of 2.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - PHARMACIE LE BRIS GOUDAL (SIREN 528895055)
Kennzahl 2025 2024 2023 2022 2021 2020 2019 2018 2017
Umsatz N/C N/C 2 003 626 € N/C N/C N/C N/C N/C N/C
Nettoergebnis 106 778 € 110 621 € 129 160 € 115 439 € 105 996 € 89 620 € 117 375 € 99 231 € 89 580 €
EBITDA N/C N/C 176 948 € N/C N/C N/C N/C N/C N/C
Nettomarge N/C N/C 6.4% N/C N/C N/C N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2025, PHARMACIE LE BRIS GOUDAL generates positive net income of 107 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 90 k€ -> 107 k€.

Nettoergebnis (2025) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

106 778 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 8%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 84%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Verschuldungsgrad (2025) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

7.627%

Finanzielle Autonomie (2025) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

83.692%

Anlagenaltersquote (2025) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

16.7%

Entwicklung der Solvenzkennzahlen
PHARMACIE LE BRIS GOUDAL

Positionnement sectoriel

Debt ratio
7.63 2025
2023
2024
2025
Q1: 13.71
Méd: 49.76
Q3: 129.07
Excellent

In 2025, the debt ratio of PHARMACIE LE BRIS GOUDAL (7.63) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
83.69% 2025
2023
2024
2025
Q1: 33.42%
Méd: 53.71%
Q3: 72.08%
Excellent +9 pts über 3 Jahre

In 2025, the financial autonomy of PHARMACIE LE BRIS GOUDAL (83.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
2.29 years 2023
2023
Q1: 0.95 years
Méd: 3.58 years
Q3: 7.48 years
Good

In 2023, the repayment capacity of PHARMACIE LE BRIS GOUDAL (2.29) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 227.76. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2025) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

227.759

Entwicklung der Liquiditätskennzahlen
PHARMACIE LE BRIS GOUDAL

Positionnement sectoriel

Liquidity ratio
227.76 2025
2023
2024
2025
Q1: 131.03
Méd: 182.29
Q3: 258.7
Good

In 2025, the liquidity ratio of PHARMACIE LE BRIS GOUDAL (227.76) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
3.93x 2023
2023
Q1: 0.38x
Méd: 2.71x
Q3: 6.47x
Good

In 2023, the interest coverage of PHARMACIE LE BRIS GOUDAL (3.9x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Umlaufvermögensbedarf und Zahlungsfristen

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 198 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 553 days. Excellent situation: suppliers finance 355 days of the operating cycle (retail model).

Operatives Working Capital (2025) ?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Formel
Stocks + Créances clients - Dettes fournisseurs
Interpretation
Negativ = freigesetzte Liquidität
Positiv = Finanzierungsbedarf

0 €

Kundenforderungen (2025) ?
Kundenforderungen (Tage)
Definition
Durchschnittliche Zahlungsfrist für Kunden.
Formel
(Kundenforderungen / Umsatz inkl. MwSt.) x 360
Interpretation
< 45j : Gut
45-60j : Durchschnitt
> 60j : Lang

198 j

Lieferantenverbindlichkeiten (2025) ?
Lieferantenverbindlichkeiten (Tage)
Definition
Durchschnittliche Zahlungsfrist von Lieferanten.
Formel
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität

553 j

Lagerumschlag (2025) ?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag

0 j

Entwicklung des Working Capital und der Zahlungsfristen
PHARMACIE LE BRIS GOUDAL

Positionnement de PHARMACIE LE BRIS GOUDAL dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE LE BRIS GOUDAL is estimated at 1 696 181 € (range 1 151 036€ - 2 661 541€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1151k€ 1696k€ 2661k€
1 696 181 € Range: 1 151 036€ - 2 661 541€
NAF 5 année 2025

Valuation method used

Net Income Multiple
106 778 € × 15.9x = 1 696 181 €
Range: 1 151 037€ - 2 661 542€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE LE BRIS GOUDAL with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE LE BRIS GOUDAL

What is the revenue of PHARMACIE LE BRIS GOUDAL ?

The revenue of PHARMACIE LE BRIS GOUDAL in 2023 is 2.0 M€.

Is PHARMACIE LE BRIS GOUDAL profitable?

Yes, PHARMACIE LE BRIS GOUDAL generated a net profit of 107 k€ in 2025.

Where is the headquarters of PHARMACIE LE BRIS GOUDAL ?

The headquarters of PHARMACIE LE BRIS GOUDAL is located in VALOGNES (50700), in the department Manche.

Where to find the tax return of PHARMACIE LE BRIS GOUDAL ?

The tax return of PHARMACIE LE BRIS GOUDAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE LE BRIS GOUDAL operate?

PHARMACIE LE BRIS GOUDAL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.